News

Belite Bio Announces Completion Of Enrollment In The Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant In Geographic Atrophy
The PHOENIX study is a 24-month, randomized, double-masked, placebo-controlled, multicenter, pivotal Phase 3 trial. The study is ongoing across sites in the United States, the United Kingdom, France, ...
Wimbledon: Keys & GB's Kartal set for early action - watch, listen & follow
Watch live coverage of day three at Wimbledon, with Carlos Alcaraz, Aryna Sabalenka and seven British players among those in ...